PSMT Form 144 Filed for 550-Share Sale via Morgan Stanley
Rhea-AI Filing Summary
PriceSmart Inc. (PSMT) filed a Form 144 reporting a proposed sale of 550 common shares, with an aggregate market value of $67,771.00, representing a small fraction of the 30,753,891 shares outstanding. The shares were acquired under a restricted stock award on 08/29/2022 from the issuer. The filing names Morgan Stanley Smith Barney LLC as the broker and lists an approximate sale date of 10/06/2025. The notice also discloses a prior 10b5-1 sale of 550 shares on 07/07/2025 with gross proceeds of $58,470.50. The filer certifies they are not aware of undisclosed material adverse information.
Positive
- Full Form 144 disclosure filed showing broker, acquisition date, and planned sale date
- Previous 10b5-1 sale disclosed (550 shares on 07/07/2025), indicating use of an established trading procedure
- Shares acquired via RSA on 08/29/2022, showing lawful grant origin
Negative
- None.
Insights
Small, routine insider sale under Rule 144 and prior 10b5-1 plan
The filing reports a proposed sale of 550 shares valued at $67,771.00, acquired via a restricted stock award on 08/29/2022. The broker is Morgan Stanley Smith Barney LLC, and the planned sale date is 10/06/2025, which aligns with standard disclosure requirements for covered securities.
This transaction appears operationally routine: the quantity is tiny relative to the 30,753,891 shares outstanding, and a prior 10b5-1 sale of 550 shares on 07/07/2025 generated $58,470.50. Monitor completion around 10/06/2025 if tracking insider liquidity activity.
Filing demonstrates affirmative compliance acknowledgments and broker routing
The notice includes the standard representation that the signer does not possess undisclosed material adverse information and cites reliance on a possible 10b5-1 trading plan for prior sales. The broker and contact details are provided, meeting routine Form 144 disclosure elements.
Key compliance checkpoints are the reported acquisition date 08/29/2022, the match between securities sold previously and disclosed amounts, and the signature attestation. If the sale executes on 10/06/2025, regulatory recordkeeping should reflect the broker confirmation and settlement details.